| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |